• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,191.76 549.28
(1.06%)
Dow Jones
7,764.37 24.43
(0.32%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.08 -0.14
(-0.15%)
EUR-INR
106.23 -0.27
(-0.26%)
GBP-INR
125.74 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Reliance Industries Ltd
Industry :  Refineries
BSE Code
ISIN Demat
Book Value()
500325
INE002A01018
418.4253247
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RELIANCE
42.21
1655435.01
EPS(TTM)
Face Value()
Div & Yield %
28.98
10
0.49
 

Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
May 13,2026
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales256.99197.99 30 927.11809.73 15
OPM %17.2910.65 -17.6915.65 -
PBDT53.5931.48 70 225.56155.06 45
PBT44.9223.44 92 192.08125.64 53
NP35.5815.54 129 129.1384.30 53